Novo Nordisk A/S Common Stock (NVO)

Net Receivables

kr 108.51B

Quarterly · Period ending: · DKK

NVO logo

NVO Net Receivables

Latest reportedkr 108.51B DKK
NVO Quarterly Net Receivables · DKK (kr 888.33M → kr 108.51B)
High-resolution chart · PNG

NVO net receivables history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Net Receivables — Quarterly (DKK)
Period endingNet Receivables (DKK)
108,512,000,000
100,268,000,000
75,697,453,000
92,373,000,000
85,843,000,000
86,366,000,000
87,414,000,000
69,497,000,000
9,551,751,889
71,750,000,000
75,261,000,000
7,685,001,135
9,388,191,681
7,530,755,263
57,505,000,000
6,337,896,414
5,903,547,554
5,884,807,826
46,799,000,000
4,714,702,077
4,216,854,980
4,729,177,695
4,606,394,345
3,903,902,957
3,909,764,238
4,691,065,756
3,863,301,787
26,522,000,000
27,000,000,000
24,650,000,000
26,889,000,000
21,568,000,000
22,332,000,000
18,651,000,000
23,551,000,000
20,153,000,000
20,855,000,000
19,668,000,000
24,197,000,000
20,187,000,000
15,756,000,000
16,502,000,000
15,485,000,000
13,565,000,000
14,209,000,000
14,648,000,000
15,791,000,000
16,258,000,000
16,777,000,000
10,481,000,000
10,907,000,000
9,721,000,000
14,878,000,000
14,425,000,000
13,584,000,000
13,831,000,000
14,070,000,000
13,417,000,000
12,608,000,000
9,522,000,000
10,097,000,000
9,685,000,000
9,150,000,000
9,006,000,000
9,312,000,000
8,867,000,000
7,862,000,000
9,397,000,000
9,873,000,000
9,420,000,000
8,724,545,200
9,102,706,650
8,217,946,200
8,050,072,250
7,313,020,000
8,341,290,700
8,427,302,200
7,478,513,200
6,498,190,000
7,305,456,420
7,384,564,000
6,580,924,350
6,121,164,580
6,469,833,300
6,092,905,500
6,138,127,080
4,571,345,730
5,960,452,440
5,935,059,260
6,090,325,920
4,387,223,400
4,699,586,160
6,031,595,220
4,708,444,400
6,528,027,830
5,704,731,214
4,769,634,132
4,623,675,922
4,362,108,200
4,040,149,960
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.